News stories about IMS Health (NYSE:IMS) have trended somewhat positive on Monday, Accern reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. IMS Health earned a daily sentiment score of 0.22 on Accern’s scale. Accern also gave headlines about the information technology services provider an impact score of 42.9495919962547 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Shares of IMS Health (NYSE:IMS) traded up $0.99 during trading on Monday, hitting $31.34. The stock had a trading volume of 4,031,300 shares, compared to its average volume of 1,266,943. The stock has a market capitalization of $10,330.00 and a P/E ratio of 74.62. IMS Health has a 12-month low of $22.36 and a 12-month high of $31.59. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 2.53.
ILLEGAL ACTIVITY WARNING: This article was originally published by Transcript Daily and is the property of of Transcript Daily. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://transcriptdaily.com/2018/01/16/ims-health-ims-earns-news-impact-score-of-0-22.html.
About IMS Health
IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
Receive News & Ratings for IMS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health and related companies with MarketBeat.com's FREE daily email newsletter.